Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$303M Buy
+152,500
New +$243M 5.5% 2
2024
Q3
Sell
-93,500
Closed -$95.6M 74
2024
Q2
$95.6M Buy
93,500
+79,500
+568% +$76.4M 3.28% 5
2024
Q1
$13.6M Buy
+14,000
New +$12.4M 0.43% 52
2022
Q4
Sell
-52,500
Closed -$22.8M 42
2022
Q3
$22.8M Sell
52,500
-35,000
-40% -$17.5M 1.23% 23
2022
Q2
$41.6M Sell
87,500
-2,500
-3% -$1.4M 3.67% 6
2022
Q1
$60.1M Buy
90,000
+32,000
+55% +$21.4M 1.84% 15
2021
Q4
$46.2M Buy
+58,000
New +$46.1M 1.69% 21
2018
Q1
Sell
-150,000
Closed -$26.1M 134
2017
Q4
$26.1M Buy
150,000
+50,000
+50% +$8.82M 0.57% 47
2017
Q3
$17.1M Buy
+100,000
New +$15.3M 0.34% 64

Other funds holding ASML

Maplelane Capital's ASML Position: Q2 2026 in Review

Maplelane Capital sold out of ASML (ASML) in Q2 2026, closing a stake of 15,000 shares — an estimated $23.9M sold.

Maplelane Capital first reported a position in ASML in Q2 2014 and held it in 11 quarters. The position peaked at $95.5M in Q2 2024. 2,504 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Maplelane Capital reported no remaining ASML position as of Q2 2026 after selling out during the quarter.
  • Maplelane Capital sold 15,000 ASML shares in Q2 2026, an estimated $23.9M.
  • Maplelane Capital first reported a position in ASML in Q2 2014 and held it in 11 quarters.
  • Maplelane Capital's ASML position peaked at $95.5M in Q2 2024.
  • 2,504 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Maplelane Capital's 13F filing for Q2 2026, filed 13 Aug 2026.